Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome
Journal of Gastroenterology and Hepatology · 2024-07 · 39 (7) · 1413-1421
DOI: 10.1111/jgh.16508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 13.02.2024. Verfasst von Hiroaki Sugita und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, 13-1 Takara-Machi, Kanazawa, 920-8641, Japan. Hauptthemen laut MEDLINE: Hepatic Veno-Occlusive Disease, Cilostazol, Hepatectomy, Phosphodiesterase 3 Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Safe radical hepatectomy is important for patients with colorectal liver metastases complicated by sinusoidal obstruction syndrome (SOS) after oxaliplatin‐based chemotherapy. This study aimed to investigate the impact of preoperative administration of cilostazol (CZ), an oral selective phosphodiesterase III inhibitor, on hepatectomy in rat SOS model. Material and Methods Rats were divided into NL (normal liver), SOS (monocrotaline [MCT]‐treated), and SOS + CZ (MCT + CZ‐treated) groups. MCT or CZ was administered orally, and a 30% partial hepatectomy was performed 48 h after MCT administration. Postoperative survival rates were evaluated ( n = 9, for each). Other rats were sacrificed on postoperative days (POD) 1 and 3 and evaluated histologically, immunohistochemically, biochemically, and using transmission electron microscopy (TEM), focusing particularly on SOS findings, liver damage, and liver sinusoidal endothelial cell (LSEC) injury.
Results
The cumulative 10‐day postoperative survival rate was significantly higher in the SOS + CZ group than in the SOS group (88.9% vs 33.3%, P = 0.001). Total SOS scores were significantly lower in the SOS + CZ group than in the SOS group on both POD 1 and 3. Serum biochemistry and immunohistochemistry showed that CZ reduced liver damage after hepatectomy. TEM revealed that LSECs were significantly preserved morphologically in the SOS + CZ group than in the SOS group on POD 1 (86.1 ± 8.2% vs 63.8 ± 9.3%, P = 0.003).
Conclusion
Preoperative CZ administration reduced liver injury by protecting LSECs and improved the prognosis after hepatectomy in rats with SOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, 13-1 Takara-Machi, Kanazawa, 920-8641, Japan.
- Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Japan.
- Department of Functional Anatomy, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Japan.
ORCID-Profile: Hiroaki Sugita
Zitieren
APA
Sugita, H., Nakanuma, S., Munesue, S., Ishikawa, T., Tokoro, T., Takei, R., Okazaki, M., Kato, K., Takada, S., Makino, I., Ozaki, N., Yamamoto, Y., & Yagi, S. (2024). Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome. Journal of Gastroenterology and Hepatology, 39(7), 1413-1421. https://doi.org/10.1111/jgh.16508
Vancouver
Sugita H, Nakanuma S, Munesue S, Ishikawa T, Tokoro T, Takei R, et al. Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome. Journal of Gastroenterology and Hepatology. 2024;39(7):1413-1421. doi:10.1111/jgh.16508
BibTeX
@article{Sugita2024,
author = {Sugita, Hiroaki and Nakanuma, Shinichi and Munesue, Seiichi and Ishikawa, Tatsuya and Tokoro, Tomokazu and Takei, Ryohei and Okazaki, Mitsuyoshi and Kato, Kaichiro and Takada, Satoshi and Makino, Isamu and Ozaki, Noriyuki and Yamamoto, Yasuhiko and Yagi, Shintaro},
title = {Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
volume = {39},
number = {7},
pages = {1413--1421},
doi = {10.1111/jgh.16508}
}
EUVIMED